- Home
- LXEO vs DMA Comparison
LXEO vs DMA Comparison
Compare LXEO & DMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LXEO
- DMA
- Stock Information
- Founded
- LXEO 2017
- DMA 2011
- Country
- LXEO United States
- DMA United States
- Employees
- LXEO N/A
- DMA N/A
- Industry
- LXEO
- DMA Trusts Except Educational Religious and Charitable
- Sector
- LXEO
- DMA Finance
- Exchange
- LXEO Nasdaq
- DMA Nasdaq
- Market Cap
- LXEO 93.9M
- DMA 77.5M
- IPO Year
- LXEO 2023
- DMA N/A
- Fundamental
- Price
- LXEO $4.49
- DMA $8.64
- Analyst Decision
- LXEO Strong Buy
- DMA
- Analyst Count
- LXEO 5
- DMA 0
- Target Price
- LXEO $16.60
- DMA N/A
- AVG Volume (30 Days)
- LXEO 520.2K
- DMA 34.6K
- Earning Date
- LXEO 08-11-2025
- DMA 01-01-0001
- Dividend Yield
- LXEO N/A
- DMA 2.04%
- EPS Growth
- LXEO N/A
- DMA N/A
- EPS
- LXEO N/A
- DMA N/A
- Revenue
- LXEO N/A
- DMA N/A
- Revenue This Year
- LXEO N/A
- DMA N/A
- Revenue Next Year
- LXEO N/A
- DMA N/A
- P/E Ratio
- LXEO N/A
- DMA N/A
- Revenue Growth
- LXEO N/A
- DMA N/A
- 52 Week Low
- LXEO $1.45
- DMA $4.78
- 52 Week High
- LXEO $19.50
- DMA $8.00
- Technical
- Relative Strength Index (RSI)
- LXEO 63.76
- DMA 46.28
- Support Level
- LXEO $3.91
- DMA $8.58
- Resistance Level
- LXEO $4.85
- DMA $8.77
- Average True Range (ATR)
- LXEO 0.33
- DMA 0.11
- MACD
- LXEO 0.02
- DMA -0.01
- Stochastic Oscillator
- LXEO 78.69
- DMA 25.09
About LXEO Lexeo Therapeutics Inc.
Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated. The company focuses on preclinical and clinical stage gene therapies, specifically hereditary and acquired diseases with high unmet needs, which represent its sole business segment.
About DMA Destra Multi-Alternative Fund
Destra Multi-Alternative Fund is a non-diversified, closed-end management investment company that operates as an interval fund with a continuous offering of fund shares. The investment objective of the fund is to seek returns from capital appreciation and income with an emphasis on income generation.